(lp0
S'Stocks: The Intercept Pharmaceuticals, Inc.  CMO David Shapiro Sells 988 ... Petro Global News 24 - Jan 19, 2017 Intercept Pharmaceuticals, Inc.  CMO David Shapiro sold 988 shares of Intercept Pharmaceuticals stock in a transaction that occurred on Tuesday, January 3rd.'
p1
aS'Stocks: The Intercept Pharmaceuticals, Inc.  Sees Large Decline in Short ... Petro Global News 24 - Jan 8, 2017 Intercept Pharmaceuticals, Inc.  saw a large drop in short interest in the month of December. As of December 15th, there was short interest totalling 4,599,808 shares, a drop of 5.9% from the November 30th total of 4,888,148 shares.'
p2
aS'Intercept Pharmaceuticals  Q4 2016 Results - Earnings Call Transcript Seeking Alpha - Feb 23, 2017 Thank you for joining the Intercept Pharmaceuticals 2016 Full Year Financial Results Conference Call. At this time, all participants are in listen-only mode.Wedbush Maintains Outperform Rating and $224 PT on Intercept Pharmaceuticals ... - StreetInsider.com'
p3
aS"Intercept Pharmaceuticals Inc  Stock Could Be Biotech's Grand Slam Investorplace.com - Jan 24, 2017 The market has begun 2017 trading sideways, but don't let that fool you into thinking there aren't opportunities out there, especially in biotech."
p4
aS'Commit To Buy Intercept Pharmaceuticals At $80, Earn 9% Annualized Using Options Nasdaq - Apr 6, 2017 Investors considering a purchase of Intercept Pharmaceuticals Inc  shares, but tentative about paying the going market price of $108.44/share, might benefit from considering selling puts among the alternative strategies at their disposal.Intercept Pharmaceuticals Inc  Expected to Post Earnings of -$4.24 Per Share - The Cerbat Gem'
p5
aS"Breaking Down: Intercept Pharmaceuticals Inc  Stock Drop Below ... CML News - 21 hours ago Intercept Pharmaceuticals Inc has a one bull  technical rating because it's trading below the 10 day, 50 day and 200 day simple moving averages while the 10-day moving average is below the 50-day moving average and the 50-day&nbsp;...Intercept Pharmaceuticals  Getting Positive News Coverage, AlphaOne Reports - Markets DailyIntercept Pharmaceuticals Inc  Earns Outperform Rating from Oppenheimer ... - BBNS"
p6
aS"How These Biotech Stocks are Faring? -- FibroGen, Bellicum Pharma, Intercept ... PR Newswire  - 23 hours ago Taking into consideration Thursday's market sentiment, Stock-Callers.com assessed the following Biotechnology equities this morning: FibroGen Inc. , Bellicum Pharmaceuticals Inc. , Intercept Pharmaceuticals Inc."
p7
aS'Trading Patterns In Focus: Kindred Healthcare, Inc. , Intercept ... Post Analyst - 19 hours ago Kindred Healthcare, Inc.  traded at an unexpectedly low level on 04/13/2017 when the stock experienced a -0.64% loss to a closing price of $7.75.'
p8
aS"Intercept Pharmaceuticals Reports Third Quarter 2016 Financial Results and ... GlobeNewswire  - Nov 3, 2016 NEW YORK, Nov. 03, 2016  -- Intercept Pharmaceuticals, Inc. , a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat non-viral, progressive liver diseases, today&nbsp;...Intercept Pharmaceuticals'  CEO Mark Pruzanski on Q3 2016 Results ... - Seeking AlphaIntercept  Reports Narrower-Than-Expected Q3 Loss November 03, 2016 - Zacks.com"
p9
aS'Trading Sheet: Reviewing the Levels for Intercept Pharmaceuticals, Inc ... Baldwin Journal - 6 hours ago Intercept Pharmaceuticals, Inc.  presently has an EV or Enterprise Value of 2455677. The EV helps show how the market assigns value to a company as a whole.'
p10
a.